English Hindi April 21, 2021


Pfizer sought approval from the India's drug regulator for emergency use authorisation of its corona vaccine

December 06, 2020 10:26 AM

New Delhi, December 6

American pharma giant Pfizer has sought approval from the country's drug regulator - the DCGI (Drugs Controller General of India) - for emergency use authorisation of its coronavirus vaccine, say sources. The vaccine is ready to be rolled out in the United Kingdom and Bahrain. This is the first such request received by the DCGI amid the race to find a vaccine for the deadly virus, which has affected over 96 lakh people in India.

In its application submitted on December 4, Pfizer India has sought approval to "import the vaccine for sale and distribution in the country, besides waiver of clinical trials on Indian population in accordance with the special provisions under the New Drugs and Clinical Trials Rules, 2019, " sources have been quoted as saying by news agency PTI.

On Wednesday, the United Kingdom became the first western country to clear the Covid-19 shot developed jointly by Pfizer and German biotechnology partner BioNTech, which has reported an efficiency of 95 per cent in third stage of trials.
- Agencies

Have something to say? Post your comment